The Enterprise Value as of December 2025 (TTM) for Enlivex Therapeutics Ltd. (ENLV) is 24.70M

According to Enlivex Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 24.70M. This represents a change of 10.55% compared to the average of 22.34M of the last 4 quarters.

Enlivex Therapeutics Ltd. (ENLV) Historical Enterprise Value (quarterly & annually)

How has ENLV Enterprise Value performed in the past?

The mean historical Enterprise Value of Enlivex Therapeutics Ltd. over the last ten years is 43.08M. The current 24.70M Enterprise Value has changed 5.63% with respect to the historical average. Over the past ten years (40 quarters), ENLV's Enterprise Value was at its highest in in the September 2019 quarter at 267.18M. The Enterprise Value was at its lowest in in the March 2019 quarter at -8131089.80.

Enlivex Therapeutics Ltd. (ENLV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Enlivex Therapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Enlivex Therapeutics Ltd. (ENLV) Average Enterprise Value

How has ENLV Enterprise Value performed in the past?

The current Enterprise Value of Enlivex Therapeutics Ltd. (ENLV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Enlivex Therapeutics Ltd. (ENLV) Enterprise Value vs. Peers

How is ENLV’s Enterprise Value compared to its peers?

Enlivex Therapeutics Ltd.’s Enterprise Value is greater than CollPlant Biotechnologies Ltd. (21.10M), greater than Lisata Therapeutics, Inc. (-1093664.00), greater than NuCana plc (11.88M), greater than MetaVia Inc. (-1392365.00), less than Exicure, Inc. (35.58M), greater than Cadrenal Therapeutics, Inc. Common Stock (19.18M), less than NeuroSense Therapeutics Ltd. (28.93M), less than NeurAxis, Inc. (24.74M), greater than CytoMed Therapeutics Limited (19.85M), greater than Passage Bio, Inc. (-3704906.00),

Build a custom stock screener for Enlivex Therapeutics Ltd. (ENLV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enlivex Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Enlivex Therapeutics Ltd. (ENLV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Enlivex Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.